Orchestra BioMed Inc.

NASDAQ: OBIO · Real-Time Price · USD
2.93
-0.05 (-1.68%)
At close: Jun 27, 2025, 2:50 PM

Orchestra BioMed Revenue

Orchestra BioMed reported an annual revenue of $2.64M, reflecting a -4.42% growth. For the quarter ending March 31, 2025, Orchestra BioMed generated $868K in revenue.
Revenue (ttm)
$2.64M
Revenue Growth
-4.42%
Price / Sales Ratio
55.83
Revenue / Employee
$37.69K
Employees
70
Market Cap
112.26M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.